Overview

Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

Status:
Not yet recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This is a randomized, open label, cohort study, in which a total of 100 patients will be enrolled and randomly assigned to receive bivalirudin or heparin in a 1:1 ratio during short-term intervention of non-infarction related artery for acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention. NACE, MACE, any type of BARC bleeding, stent thrombosis will be evaluated in 30 days and 6 months after recruitment.

Phase:

N/A

Details

Lead Sponsor:

First Affiliated Hospital Xi'an Jiaotong University

Collaborators:

Hanzhong Central Hospital
Shaanxi Provincial People's Hospital
Xiangyang Central Hospital
Xianyang Central Hospital
Yan'an University Affiliated Hospital

Treatments:

Bivalirudin
Heparin